Abstract | PURPOSE: A priori identification of the small proportion of radiation therapy patients who prove to be severely radiosensitive is a long-held goal in radiation oncology. A number of published studies indicate that analysis of the DNA damage response after ex vivo irradiation of peripheral blood lymphocytes, using the γ-H2AX assay to detect DNA damage, provides a basis for a functional assay for identification of the small proportion of severely radiosensitive cancer patients undergoing radiotherapy. METHODS AND MATERIALS: We introduce a new, more rigorous, integrated approach to analysis of radiation-induced γ-H2AX response, using Bayesian statistics. RESULTS: This approach shows excellent discrimination between radiosensitive and non-radiosensitive patient groups described in a previously reported data set. CONCLUSIONS: Bayesian statistical analysis provides a more appropriate and reliable methodology for future prospective studies.
|
Authors | Alan Herschtal, Roger F Martin, Trevor Leong, Pavel Lobachevsky, Olga A Martin |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 102
Issue 3
Pg. 627-634
(11 01 2018)
ISSN: 1879-355X [Electronic] United States |
PMID | 30244880
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- H2AX protein, human
- Histones
|
Topics |
- Bayes Theorem
- Biomarkers
- DNA Damage
- Databases, Factual
- Dose-Response Relationship, Radiation
- Female
- Histones
(chemistry)
- Humans
- Lymphocytes
(radiation effects)
- Male
- Models, Theoretical
- Monte Carlo Method
- Neoplasms
(blood, radiotherapy)
- Prospective Studies
- Radiation Tolerance
(genetics)
- Radiotherapy
- Reproducibility of Results
- Retrospective Studies
- Time Factors
|